← back to search

Silvia Angeletti

Università Campus Bio-Medico · IT
Area of research
Infectious Diseases · Epidemiology
Research interest
Research focused on Mutation and Phylogenetic tree, with related work in Virology, Coronavirus, Genome. Notable publications include 'Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant', 'Application of the ARIMA model on the COVID-2019 epidemic dataset', and 'The 2019‐new coronavirus epidemic: Evidence for virus evolution'.
h-index
citations
7,555
works
235
NIH funding
primary concept
email

Recent publications

Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non–small cell lung cancer
Journal of Translational Medicine 2026cited by 0position: middledoi
Additional file 1 of Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non–small cell lung cancer
Open MIND 2026cited by 0position: middledoi
Additional file 1 of Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non–small cell lung cancer
Figshare 2026cited by 0position: middledoi
Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis
Diagnostics 2025cited by 6position: lastdoi
Machine Learning for Predicting the Low Risk of Postoperative Pancreatic Fistula After Pancreaticoduodenectomy: Toward a Dynamic and Personalized Postoperative Management Strategy
Cancers 2025cited by 3position: middledoi
Small Bowel Volvulus Caused by Meckel's Diverticulum
Annali Italiani di Chirurgia 2025cited by 1position: middledoi
Genomic Surveillance and Resistance Profiling of Multidrug-Resistant Acinetobacter baumannii Clinical Isolates: Clonal Diversity and Virulence Insights
Microorganisms 2025cited by 1position: lastdoi
Salivary Microbial Signature Highlighting Actinomyces as a Predictor of Immune-Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer.
Research Square 2025cited by 0position: middledoi
Role of the Gut Microbiota in Osteoarthritis, Rheumatoid Arthritis, and Spondylarthritis: An Update on the Gut–Joint Axis
International Journal of Molecular Sciences 2024cited by 53position: middledoi
Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential
Frontiers in Immunology 2024cited by 25position: middledoi
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision
Genes 2024cited by 23position: lastdoi
A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections
Cells 2024cited by 15position: lastdoi
The influence of gut microbiome on periprosthetic joint infections: State-of-the art
Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine 2024cited by 10position: middledoi
Multidrug-Resistant Klebsiella pneumoniae Strains in a Hospital: Phylogenetic Analysis to Investigate Local Epidemiology
Microorganisms 2024cited by 6position: lastdoi
Improving the diagnosis of AATD with aid of serum protein electrophoresis: a prospective, multicentre, validation study
Clinical Chemistry and Laboratory Medicine (CCLM) 2024cited by 1position: middledoi
Phylogenetic analysis of <i>Prevotella copri</i> from fecal and mucosal microbiota of IBS and IBD patients
Therapeutic Advances in Gastroenterology 2023cited by 20position: middledoi
Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure
Journal of Personalized Medicine 2023cited by 19position: lastdoi
Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5
Microorganisms 2023cited by 16position: middledoi
Orodispersible Film Based on Maltodextrin: A Convenient and Suitable Method for Iron Supplementation
Pharmaceutics 2023cited by 11position: middledoi
Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?
International Journal of Molecular Sciences 2023cited by 9position: lastdoi
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles
Frontiers in Immunology 2023cited by 9position: middledoi
Postoperative procalcitonin is a biomarker for excluding the onset of clinically relevant pancreatic fistula after pancreaticoduodenectomy
Journal of Gastrointestinal Oncology 2023cited by 4position: middledoi
Meningococcal Conjunctivitis in a 54-Year-Old Man: Case Report and Review of the Literature
Chemotherapy 2023cited by 2position: middledoi
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications
International Orthopaedics 2023cited by 2position: middledoi
Editorial: Diagnostic accuracy of sepsis: clinical scores combination and serum biomarkers for rapid diagnosis and prognosis
Frontiers in Medicine 2023cited by 1position: lastdoi
Associated effects of clinical characteristics, risk factors, and comorbidity on disease severity and mortality among patients with COVID-19 in Sulaimani City/ Kurdistan Region of Iraq.
PubMed 2023cited by 0position: middle
POS0237 ADULT-ONSET STILL’S DISEASE AND COVID 19 SHARE GENETIC EXPRESSION RELATED TO HYPERINFLAMMATION: DEFINING THE POSSIBLE ROLE OF THE SPECIALIZED PRO-RESOLVING LIPID MEDIATOR PROTECTIN D1 IN MODULATING MACROPHAGES POLARIZATION AND FUNCTION
2023cited by 0position: middledoi
On the SARS‐CoV‐2 BA.2.75 variant: A genetic and structural point of view
Journal of Medical Virology 2022cited by 30position: middledoi
Genetic Variability of the Monkeypox Virus Clade IIb B.1
Journal of Clinical Medicine 2022cited by 30position: middledoi
Active Surveillance Cultures and Procalcitonin in Combination With Clinical Data to Guide Empirical Antimicrobial Therapy in Hospitalized Medical Patients With Sepsis
Frontiers in Microbiology 2022cited by 18position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Massimo Ciccozzi · Materials Research Group (United States)161 papers (2015–2024)Eleonora Cella · University of Florida61 papers (2015–2022)Silvia Spoto · Università Campus Bio-Medico55 papers (2015–2025)Marta Giovanetti · Clinics Hospital of Ribeirão Preto42 papers (2015–2023)Marta Fogolari · Università Campus Bio-Medico36 papers (2015–2026) · 35 papers (2015–2023)Giordano Dicuonzo · Università Campus Bio-Medico34 papers (2012–2019)Lucia De Florio · Università Campus Bio-Medico27 papers (2013–2025)Domenico Benvenuto · Università Cattolica del Sacro Cuore27 papers (2019–2022)Giancarlo Ceccarelli · Imperial College Healthcare NHS Trust24 papers (2016–2022)Sebastiano Costantino · Università Campus Bio-Medico22 papers (2015–2023)Roberto Coppola · Università Campus Bio-Medico22 papers (2016–2025)E. Riva · Università Campus Bio-Medico21 papers (2013–2024)Damiano Caputo · Università Campus Bio-Medico21 papers (2018–2025) · 20 papers (2016–2023)Marina De Cesaris · Università Campus Bio-Medico17 papers (2015–2025) · 17 papers (2015–2020)Alessandro Coppola · Università Campus Bio-Medico16 papers (2018–2023)Vincenzo La Vaccara · Università Campus Bio-Medico16 papers (2018–2025)Marta Fogolari · Università Campus Bio-Medico15 papers (2016–2020)